[The traditional Chinese medicine sector bucked the trend and strengthened, and Kunming Pharmaceutical Group hit its daily limit] On October 19, the traditional Chinese medicine sector bucked the trend and strengthened, Kunming Pharmaceutical Group hit its daily limit, with Darentang, Jichuan Pharmaceutical, Pien Tze Huang, China Resources Jiangzhong, Dong'e Ejiao, and Tongrentang leading the gains. On the news, CITIC Securities Research reported that the market style has become cautious recently, and attention to high-dividend targets of traditional Chinese medicine continues to rise. Against this background, the traditional Chinese medicine sector has become a segmented investment sector with high certainty by virtue of its triple attributes of "low valuation + high dividend + cost improvement".